Skip to main content
ImmuneCited

Vitamin D 관련 Immune Aging (Immunosenescence)

B

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

Key Study Findings

Review
Fanconi anaemia as a human model of accelerated epigenetic and immune ageing.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: patients with Fanconi anaemia

Randomized Controlled Trial n=124
Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg …
Dose: 2500 IU vitamin D + 1000 mcg B12 vs: Separate D+B12 and no supplementation control Outcome: Serum 25-OH-D and B12 level restoration 효과: 37.1% adequate vs 29.4% separate None

대상 집단: Adults with vitamin D (<20ng/mL) and B12 (<250ng/L) insufficiency

Observational Study n=72
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Dose: None vs: Healthy controls Outcome: CVR and systemic inflammation in alopecia areata 효과: None None

대상 집단: 36 AA patients vs 36 matched controls, mean age 39

Controlled Clinical Trial
Vitamin D stimulates Il-15 synthesis in rodent muscle.
Dose: Single dose (rats); variable (in vitro) vs: Untreated controls; VDR-KO mice Outcome: IL-15 gene expression in skeletal muscle 효과: None None

대상 집단: C2C12 myotubes, rats, VDR-KO mice

Randomized Controlled Trial 8 weeks
Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus …
Dose: Topical ointment application (3 arms) vs: 3-arm: mometasone vs calcipotriol vs tacrolimus Outcome: SALT score change at 8 weeks 효과: None <0.001 (momet, calcipot)

대상 집단: Patients with localized alopecia areata

Other
Modelling the influence of vitamin D and probiotics on inflammation and the intestinal microbiota in …
Dose: None vs: No supplementation (modeled) Outcome: Epithelial barrier integrity and immune response 효과: None None

대상 집단: Older adults (mathematical model)

Key Statistics

10

연구

5000

참여자

Positive

B

등급

Referenced Papers

Biochemistry and biophysics … 2025
International journal of … 2023 54 인용
Autoimmunity reviews 2023 24 인용
Physiological research 2021 2 인용
Advances in chronic … 2019 326 인용
Actas dermo-sifiliograficas 2019 43 인용
Postepy dermatologii i … 2017 31 인용
World journal of … 2016 238 인용
Ageing research reviews 2016 142 인용
Postepy dermatologii i … 2016 59 인용
Indian dermatology online … 2016 51 인용
World journal of … 2015 62 인용
The American journal … 2014 125 인용
European journal of … 2012 225 인용
Inflammatory bowel diseases 2012 224 인용
Gerontology 2011 27 인용
Gastroenterology 2010 390 인용
Artificial organs 2006 76 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
600-800 IU/day
immunesupport:
1,000-2,000 IU/day
deficiencycorrection:
4,000-5,000 IU/day (under medical supervision)

상한량: 4,000 IU/day (100 mcg)

연구에서 사용된 용량

용량 기간 효과 N
None -- Negative --
2500 IU vitamin D + 1000 mcg B12 -- Positive 124
None -- Negative 72
Single dose (rats); variable (in vitro) -- Positive --
Topical ointment application (3 arms) 8 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

권장 복용 시간: With a meal containing fat for better absorption

Safety & Side Effects

보고된 부작용

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

알려진 상호작용

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

일일 최대 섭취 허용량: 4,000 IU/day (100 mcg)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Vitamin D help with Immune Aging (Immunosenescence)?
Based on 10 studies with 5,000 participants, there is moderate evidence from clinical studies that Vitamin D may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Immune Aging (Immunosenescence)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Immune Aging (Immunosenescence)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 5,000 total participants. The overall direction of effect is positive.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.